Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Anhui Jinhe Industrial Co. Ltd. currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners and are distributed across 2 distinct art units. This indicates that the company's patent activity is being reviewed by two different technical departments. Operating within 2 distinct art units means the company must navigate two separate sets of administrative guidelines for their pharmaceutical filings. This structure provides a safeguard against the specific biases of any single art unit.
Jennifer C Sawyer is the busiest examiner for this portfolio, managing 1 pending office action. Since there are 2 distinct examiners for 2 pending office actions, each examiner is responsible for exactly one action. This one to one ratio between examiners and actions prevents any single official from having a majority influence over the company's current pending portfolio. The involvement of 2 distinct examiners across 2 distinct art units provides the company with two independent review processes for their innovations, ensuring that their Biotechnology & Pharmaceuticals portfolio is not dependent on a single examiner's decision.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAWYER, JENNIFER C | 1 | 68.4% | -8.2% |
| SHIM, DAVID M. | 1 | 58.8% | +58.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18304403 | DMF RECYCLING METHOD | SAWYER, JENNIFER C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18027345 | METHOD FOR REFINING ACESULFAME POTASSIUM | SHIM, DAVID M. | 33d |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18304403 | DMF RECYCLING METHOD | SAWYER, JENNIFER C | 1691 | §103§112 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18027345 | METHOD FOR REFINING ACESULFAME POTASSIUM | SHIM, DAVID M. | 1626 | §103 | Non-Final OA | 33d | Pending | Mar 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAnhui Jinhe Industrial Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jennifer C Sawyer has the most, with 1 of Anhui Jinhe Industrial Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
